vs
eXp World Holdings, Inc.（EXPI）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
eXp World Holdings, Inc.的季度营收约是Revvity的1.5倍（$1.2B vs $772.1M），Revvity净利率更高（12.7% vs -1.1%，领先13.8%），eXp World Holdings, Inc.同比增速更快（8.5% vs 5.9%），Revvity自由现金流更多（$161.8M vs $11.9M），过去两年eXp World Holdings, Inc.的营收复合增速更高（12.4% vs 9.0%）
eXp World Holdings是全球云原生房地产服务提供商，运营eXp Realty经纪网络，依托沉浸式3D虚拟园区支持代理人协作与日常运营，业务覆盖全球20余个国家的住宅及商业地产市场，同时提供按揭贷款、产权保险、从业者职业培训等配套服务。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
EXPI vs RVTY — 直观对比
营收规模更大
EXPI
是对方的1.5倍
$772.1M
营收增速更快
EXPI
高出2.7%
5.9%
净利率更高
RVTY
高出13.8%
-1.1%
自由现金流更多
RVTY
多$149.9M
$11.9M
两年增速更快
EXPI
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $772.1M |
| 净利润 | $-12.9M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | -1.1% | 14.5% |
| 净利率 | -1.1% | 12.7% |
| 营收同比 | 8.5% | 5.9% |
| 净利润同比 | -35.7% | 3.9% |
| 每股收益（稀释后） | $-0.08 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXPIRVTY
| Q4 25 | $1.2B | $772.1M | ||
| Q3 25 | $1.3B | $698.9M | ||
| Q2 25 | $1.3B | $720.3M | ||
| Q1 25 | $954.9M | $664.8M | ||
| Q4 24 | $1.1B | $729.4M | ||
| Q3 24 | $1.2B | $684.0M | ||
| Q2 24 | $1.3B | $691.7M | ||
| Q1 24 | $943.1M | $649.9M |
净利润EXPIRVTY
| Q4 25 | $-12.9M | $98.4M | ||
| Q3 25 | $3.5M | $46.7M | ||
| Q2 25 | $-2.3M | $53.9M | ||
| Q1 25 | $-11.0M | $42.2M | ||
| Q4 24 | $-9.5M | $94.6M | ||
| Q3 24 | $-8.5M | $94.4M | ||
| Q2 24 | $12.4M | $55.4M | ||
| Q1 24 | $-15.6M | $26.0M |
毛利率EXPIRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 99.9% | 56.3% | ||
| Q2 24 | 99.9% | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率EXPIRVTY
| Q4 25 | -1.1% | 14.5% | ||
| Q3 25 | 0.3% | 11.7% | ||
| Q2 25 | -0.2% | 12.6% | ||
| Q1 25 | -1.1% | 10.9% | ||
| Q4 24 | -1.0% | 16.3% | ||
| Q3 24 | -0.7% | 14.3% | ||
| Q2 24 | 1.4% | 12.4% | ||
| Q1 24 | -1.9% | 6.8% |
净利率EXPIRVTY
| Q4 25 | -1.1% | 12.7% | ||
| Q3 25 | 0.3% | 6.7% | ||
| Q2 25 | -0.2% | 7.5% | ||
| Q1 25 | -1.2% | 6.4% | ||
| Q4 24 | -0.9% | 13.0% | ||
| Q3 24 | -0.7% | 13.8% | ||
| Q2 24 | 1.0% | 8.0% | ||
| Q1 24 | -1.7% | 4.0% |
每股收益（稀释后）EXPIRVTY
| Q4 25 | $-0.08 | $0.86 | ||
| Q3 25 | $0.02 | $0.40 | ||
| Q2 25 | $-0.01 | $0.46 | ||
| Q1 25 | $-0.07 | $0.35 | ||
| Q4 24 | $-0.06 | $0.77 | ||
| Q3 24 | $-0.06 | $0.77 | ||
| Q2 24 | $0.08 | $0.45 | ||
| Q1 24 | $-0.10 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.2M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $242.8M | $7.3B |
| 总资产 | $442.5M | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EXPIRVTY
| Q4 25 | $124.2M | $919.9M | ||
| Q3 25 | $112.8M | $931.4M | ||
| Q2 25 | $94.6M | $991.8M | ||
| Q1 25 | $115.7M | $1.1B | ||
| Q4 24 | $113.6M | $1.2B | ||
| Q3 24 | $130.4M | $1.2B | ||
| Q2 24 | $108.4M | $2.0B | ||
| Q1 24 | $109.2M | $1.7B |
股东权益EXPIRVTY
| Q4 25 | $242.8M | $7.3B | ||
| Q3 25 | $235.3M | $7.4B | ||
| Q2 25 | $218.4M | $7.6B | ||
| Q1 25 | $212.0M | $7.6B | ||
| Q4 24 | $204.9M | $7.7B | ||
| Q3 24 | $211.1M | $7.9B | ||
| Q2 24 | $220.3M | $7.9B | ||
| Q1 24 | $222.4M | $7.8B |
总资产EXPIRVTY
| Q4 25 | $442.5M | $12.2B | ||
| Q3 25 | $458.7M | $12.1B | ||
| Q2 25 | $481.2M | $12.4B | ||
| Q1 25 | $435.8M | $12.4B | ||
| Q4 24 | $390.7M | $12.4B | ||
| Q3 24 | $432.6M | $12.8B | ||
| Q2 24 | $457.4M | $13.4B | ||
| Q1 24 | $426.7M | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $11.9M | $161.8M |
| 自由现金流率自由现金流/营收 | 1.0% | 21.0% |
| 资本支出强度资本支出/营收 | 0.2% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $109.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流EXPIRVTY
| Q4 25 | $13.8M | $182.0M | ||
| Q3 25 | $28.9M | $138.5M | ||
| Q2 25 | $36.1M | $134.3M | ||
| Q1 25 | $39.8M | $128.2M | ||
| Q4 24 | $13.7M | $174.2M | ||
| Q3 24 | $46.0M | $147.9M | ||
| Q2 24 | $71.1M | $158.6M | ||
| Q1 24 | $60.7M | $147.6M |
自由现金流EXPIRVTY
| Q4 25 | $11.9M | $161.8M | ||
| Q3 25 | $26.6M | $120.0M | ||
| Q2 25 | $33.3M | $115.5M | ||
| Q1 25 | $37.3M | $112.2M | ||
| Q4 24 | $11.6M | $149.8M | ||
| Q3 24 | $44.4M | $125.6M | ||
| Q2 24 | $69.7M | $136.6M | ||
| Q1 24 | $59.3M | $129.7M |
自由现金流率EXPIRVTY
| Q4 25 | 1.0% | 21.0% | ||
| Q3 25 | 2.0% | 17.2% | ||
| Q2 25 | 2.5% | 16.0% | ||
| Q1 25 | 3.9% | 16.9% | ||
| Q4 24 | 1.1% | 20.5% | ||
| Q3 24 | 3.6% | 18.4% | ||
| Q2 24 | 5.4% | 19.7% | ||
| Q1 24 | 6.3% | 20.0% |
资本支出强度EXPIRVTY
| Q4 25 | 0.2% | 2.6% | ||
| Q3 25 | 0.2% | 2.6% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.3% | 2.4% | ||
| Q4 24 | 0.2% | 3.4% | ||
| Q3 24 | 0.1% | 3.3% | ||
| Q2 24 | 0.1% | 3.2% | ||
| Q1 24 | 0.1% | 2.7% |
现金转化率EXPIRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | 8.26× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | 5.75× | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXPI
| North American Realty | $1.1B | 96% |
| International Realty | $42.2M | 4% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
